Q1 Earnings Forecast for Teleflex Issued By Citizens Jmp

Teleflex Incorporated (NYSE:TFX) – Citizens Jmp issued their Q1 2025 EPS estimates for shares of Teleflex in a report issued on Wednesday, April 2nd. Citizens Jmp analyst D. Turkaly anticipates that the medical technology company will earn $2.77 per share for the quarter. Citizens Jmp currently has a “Market Perform” rating on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Citizens Jmp also issued estimates for Teleflex’s Q2 2025 earnings at $3.45 EPS, Q3 2025 earnings at $3.70 EPS, Q4 2025 earnings at $4.18 EPS, FY2025 earnings at $14.10 EPS, Q1 2026 earnings at $3.47 EPS, Q2 2026 earnings at $3.80 EPS, Q3 2026 earnings at $3.88 EPS, Q4 2026 earnings at $4.10 EPS and FY2026 earnings at $15.25 EPS.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%.

TFX has been the topic of a number of other research reports. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Wells Fargo & Company dropped their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Truist Financial dropped their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Teleflex presently has a consensus rating of “Hold” and a consensus price target of $182.63.

Teleflex Stock Down 2.6 %

Shares of TFX opened at $127.35 on Monday. The stock’s 50-day moving average price is $151.67 and its 200-day moving average price is $184.24. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $5.90 billion, a price-to-earnings ratio of 25.32, a PEG ratio of 1.73 and a beta of 1.19. Teleflex has a 52 week low of $125.92 and a 52 week high of $249.91.

Institutional Trading of Teleflex

A number of institutional investors have recently made changes to their positions in the company. Norges Bank purchased a new position in Teleflex in the 4th quarter valued at $100,328,000. Invesco Ltd. lifted its stake in shares of Teleflex by 48.1% in the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock worth $190,188,000 after buying an additional 347,003 shares in the last quarter. Diamond Hill Capital Management Inc. acquired a new position in Teleflex during the fourth quarter worth about $46,696,000. T. Rowe Price Investment Management Inc. grew its stake in Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock valued at $1,098,693,000 after acquiring an additional 261,279 shares in the last quarter. Finally, Magnetar Financial LLC raised its holdings in Teleflex by 105.2% in the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company’s stock valued at $74,990,000 after acquiring an additional 215,961 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.07%. Teleflex’s payout ratio is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.